Basic Information
| RNALocate ID: | RLID:11003926 |
| RNA Symbol: | hsa-miR-335-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-335-3p |
| RNA ID: | miRBase:MIMAT0004703 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003925 | Exosome | Breast milk | 22211110 |
| RLID:11003927 | Exosome | Serum | 24683445 |
| RLID-D:11000201 | Exosome | Breast milk|Endothelial cells | |
| RLID-D:11000675 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-335-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-40897 |
| MNDR | hsa-miR-335-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-40898 |
| MNDR | hsa-miR-335-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-40899 |
| MNDR | hsa-miR-335-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-40900 |
| MNDR | hsa-miR-335-3p | Her2-receptor positive breast cancer | MNDR-E-MI-40901 |
| MNDR | hsa-miR-335-3p | Breast cancer luminal | MNDR-E-MI-40902 |
| MNDR | hsa-miR-335-3p | Prostate cancer | MNDR-E-MI-40903 |
| MNDR | hsa-miR-335-3p | Gastric cancer | MNDR-E-MI-40904 |
| MNDR | hsa-miR-335-3p | Alzheimer disease | MNDR-E-MI-40905 |
| MNDR | hsa-miR-335-3p | Esophageal carcinoma | MNDR-E-MI-40906 |
| MNDR | hsa-miR-335-3p | Seizures | MNDR-E-MI-40907 |
| MNDR | hsa-miR-335-3p | Friedreich ataxia | MNDR-E-MI-40908 |
| MNDR | hsa-miR-335-3p | Cardiovascular disease | MNDR-E-MI-40909 |
| MNDR | hsa-miR-335-3p | Parkinson disease | MNDR-E-MI-40910 |
| MNDR | hsa-miR-335-3p | Breast cancer | MNDR-E-MI-40911 |
| MNDR | hsa-miR-335-3p | Thyroid cancer | MNDR-E-MI-40912 |
| MNDR | hsa-miR-335-3p | Pancreatic cancer | MNDR-E-MI-40913 |
| MNDR | hsa-miR-335-3p | Melanoma | MNDR-E-MI-40914 |
| MNDR | hsa-miR-335-3p | Rectum adenocarcinoma | MNDR-E-MI-40915 |
| MNDR | hsa-miR-335-3p | Nephroblastoma | MNDR-E-MI-40916 |
| MNDR | hsa-miR-335-3p | Colon cancer | MNDR-E-MI-40917 |
| MNDR | hsa-miR-335-3p | Colon adenocarcinoma | MNDR-E-MI-40918 |
| MNDR | hsa-miR-335-3p | Familial ovarian cancer | MNDR-E-MI-40919 |
| MNDR | hsa-miR-335-3p | Carcinoma ductal breast | MNDR-E-MI-40920 |
| MNDR | hsa-miR-335-3p | Astrocytoma | MNDR-E-MI-40921 |
| MNDR | hsa-miR-335-3p | Osteosarcoma | MNDR-E-MI-40922 |
| MNDR | hsa-miR-335-3p | Breast carcinoma | MNDR-E-MI-40923 |
| MNDR | hsa-miR-335-3p | Gastric adenocarcinoma | MNDR-E-MI-40924 |
| MNDR | hsa-miR-335-3p | Lung squamous cell carcinoma | MNDR-E-MI-40925 |
| MNDR | hsa-miR-335-3p | Lung adenocarcinoma | MNDR-E-MI-40926 |
| MNDR | hsa-miR-335-3p | Thyroid carcinoma | MNDR-E-MI-40927 |
| MNDR | hsa-miR-335-3p | Bladder urothelial carcinoma | MNDR-E-MI-40928 |
| MNDR | hsa-miR-335-3p | Pancreatic adenocarcinoma | MNDR-E-MI-40929 |
| MNDR | hsa-miR-335-3p | Carcinoma renal cell | MNDR-E-MI-40930 |
| MNDR | hsa-miR-335-3p | Renal clear cell carcinoma | MNDR-E-MI-40931 |
| MNDR | hsa-miR-335-3p | Cholangiocarcinoma | MNDR-E-MI-40932 |
| MNDR | hsa-miR-335-3p | Esophageal cancer | MNDR-E-MI-40933 |
| MNDR | hsa-miR-335-3p | Lung small cell carcinoma | MNDR-E-MI-40934 |
| MNDR | hsa-miR-335-3p | Testicular germ cell cancer | MNDR-E-MI-40935 |
| MNDR | hsa-miR-335-3p | Breast invasive carcinoma | MNDR-E-MI-40936 |
| MNDR | hsa-miR-335-3p | Hepatocellular carcinoma | MNDR-E-MI-40937 |
| MNDR | hsa-miR-335-3p | Familiar ovarian carcinoma | MNDR-E-MI-40938 |
| MNDR | hsa-miR-335-3p | Rheumatoid arthritis | MNDR-E-MI-40939 |
| MNDR | hsa-miR-335-3p | Barrett's adenocarcinoma | MNDR-E-MI-40940 |
| MNDR | hsa-miR-335-3p | Hodgkin lymphoma | MNDR-E-MI-40941 |
| MNDR | hsa-miR-335-3p | Burkitt lymphoma | MNDR-E-MI-40942 |
| MNDR | hsa-miR-335-3p | Neuromyelitis optica | MNDR-E-MI-40943 |
| MNDR | hsa-miR-335-3p | Skin cutaneous melanoma | MNDR-E-MI-40944 |
| MNDR | hsa-miR-335-3p | Skin melanoma | MNDR-E-MI-40945 |
| MNDR | hsa-miR-335-3p | Colorectal cancer | MNDR-E-MI-40946 |
| MNDR | hsa-miR-335-3p | Aids dementia complex | MNDR-E-MI-40947 |
| MNDR | hsa-miR-335-3p | Gait ataxia | MNDR-E-MI-40948 |
| MNDR | hsa-miR-335-3p | Barrett's carcinogenesis | MNDR-E-MI-40949 |
| MNDR | hsa-miR-335-3p | Breast cancer her3+ negative | MNDR-E-MI-40950 |
| MNDR | hsa-miR-335-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-40951 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | NOS3 | Homo sapiens | RR01010987 |
TOP